Investors Contact Payment Careers Research Request
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director

Jan 27, 2022

Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering

Jan 12, 2022

Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offering

Jan 3, 2022

Interpace Biosciences Announces Third Quarter 2021 Financial and Business Results

Nov 10, 2021

Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans

Nov 2, 2021

Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions

Oct 28, 2021

Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms

Oct 21, 2021

Interpace Biosciences Announces New $7.5 Million Credit Facility with Comerica Bank

Oct 15, 2021

Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results

Aug 10, 2021

Interpace Pharma Solutions Announces New Capability in Spatial Biology/Precision Oncology Services

May 17, 2021
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...22
    © 2023 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin